Objective: To screen proteins of human pancreas cDNA library interacting with HCV NS3 protein.
Background and Aims: In past, EPI-Pakistan focused primarily on diseases like Polio/Measles/Mumps/Tuberculosis, but as figures switched from 238 Polio, 0.3 Million Hepatitis-B and nearly 0.45 Million Hepatitis-C registered cases in 1997 to 30 Polio, 5.3 Million Hepatitis-B and 4.9 Million Hepatitis-C cases in 2007, government changed the policy, making a stress over Hepatitis-B control. HBV/HCV is well known to cause hepatitis/related complications throughout the world, proving a threatening challenge to developing countries. Study aim was to estimate seropositivity levels of HBV/HCV among apparently healthy young population. Methods: Study was conducted at Holy-Family Hospital Rawalpindi, Pakistan. Over a period of 6months, 500cases aged between 20 40Years including 50Doctors and 450 routine blood-donors were screened after written-informed consent. They had neither any sign nor symptom of acute/chronic liver-disease. Samples were screened for HBsAg and Anti-HCV-antibodies. Cases found positive for HCV-Ab were interviewed for possible risk factors. Results: Overall 52% were male, 6.4% positive for HBsAg, male-female ratio 38:27, mean-age 24±4 years, 4.7% positive for Anti-HCV-antibodies, mean-age 25±3 years and 0.33% positive for both. Overall infection-rate was 3.3%. Prevalence-rate of Anti-HCV-antibodies (4.7%) was less than HBsAg positivity (6.4%). There was no significant overlap (0.5%) between seropositivity of Anti-HCV with HBsAg, reflecting different epidemiological-factors. Cases with Anti-HCV antibodies were further evaluated; 56% were with raised ALT, 79% had risk factors including blood-group testing (71%), parenteral-medications/needle/prick-injuries (71%), dental-procedures (19%), previous-surgery/tattoo-markings (15%), unsafe-sex (19%) and multiple blood-transfusions (2%). 7% gave no history of possible exposure. 16 doctors positive for virus (14Hep-B and 2Hep-C), all gave history of needle-prick injuries. Conclusion: Hepatitis B-Vaccine inclusion in EPI-Pakistan will decline its prevalence but HCV mostly spread via health-care facilities, so behavior-modification is superior to clinical therapy as minimizing all types of needle-pricks is advised till proper aseptic practice. Acknowledgement: Dr. Abbas Hayat, Dr. Sara Tajammul, Dr. Aamra Sartaj and Ali Mumtaz. Aim: To understand gene expression influence after the interaction between HCV NS4A and CAML. Methods: The expressive vector of pCMV/Myc-NS4A and pcDNA3.1/HisA-CAML were constructed by routine molecular biological methods. The 293 cells were transfected by pCMV/Myc-NS4A and pcDNA3.1/HisA-CAML, respectively using lipofectamine. The total RNA was isolated and reverse transcribed. The cDNAs were subjected for microarray screening. Results: The expressive vector has been constructed and confirmed by restriction enzyme digestion and DNA sequencing analysis. The expression of CAML protein has been confirmed by Western blot with single chain variable region (scFv) antibody. High quality mRNA and cDNA had been prepared and successful microarray screening had been conducted. From the scanning results, it was found 7 genes related to cell apoptosis, among them, 4 were up-regulated and 3 were down-regulated. Conclusion: The expression of NS4A protein affected the expression spectrum of 293-CAMLcells, especially some genes related to cell apoptosis pass way. HCV NS4A maybe will have some negative effect on the progress of cell apoptosis, and then lead to the chronic HCV infection. We found that 1.587%, 0.862% and 0.499% respectively of blood donors were repeatedly reactive for HCV-Ab. The confirmatory result in the same period were: 0.311%, 0.314% and 0.294% respectively. The repeatedly reactive samples were significantly reduced after change the screening kit. Our findings showed that HCV prevalence was less than some of other regions in our country and some neighbor's prevalence. Our strategy in reducing HCV prevalence such as donor selection and educational program was great effective and meet our goal in enhancing blood safety. Establishment that strategy for other centers in our province recommended.
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OL-053 Screening and identification of genes trans-regulated by HCV p7 protein with microarray assay J. Guo *, J. Cheng, H.C. Xing. Institute of Infectious Diseases, Beijing Ditan Hospital, Beijing, 100011, China Introduction: Hepatitis C virus (HCV) is a major cause of chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma throughout the world. Although HCV cannot be incubated efficiently in vitro, several of its key features have been elucidated in the past few years. HCV, cloned successfully via molecule biological technology, is an enveloped, positive single-stranded RNA (9.6-kb) virus belonging to the Flaviviridae. The HCV genome has only one ORF which is flanked by a 5 and 3 noncoding region. The ORF encodes for a large polyprotein precursor of about 3 000 amino acid residues, and this precursor protein is cleaved by the host and viral proteinases to generate at least 10 proteins in the following order: NH2-C-E1-E2-p7-NS2-NS3-NS4A-NS4B-NS5A-NS5B-COOH. HCV proteins not only function in viral replication but also affect a variety of cellular functions. HCV p7, which is located between the E2 and NS2 proteins, is a 63 residue peptide encoded by HCV genome between 2 580 2 768 nt. Although there are studies on the genomic structure, synthesis and function of p7 protein, the role of the HCV p7 protein in the virus life cycle is not known. To gain more information on the HCV p7 protein, and provide some new clues for elucidating the potential biological function of p7, we use cDNA microarray technique to screen genes regulated by p7. Method: To investigate the biological functions of hepatitis C virus p7, and to use cDNA microarray technique to screen genes regulated by p7. The HCV p7 coding DNA fragment was amplified with polymerase chain reaction (PCR) technique by using PBRTM plasmid containing the full length of HCV genome as the template. The expressive vector of pcDNA3.1-p7 was constructed by routine molecular biological methods. The HepG2 cells were transfected by pcDNA3.1( ) and pcDNA3.1-p7, respectively using FuGENE6 transfection Reagent. The total RNA was isolated and reverse transcribed. The cDNAs were subjected for microarray screening with 1152 cDNA probes. The expressive vector has been constructed and confirmed by restriction enzyme digestion and DNA sequencing analysis. High quality mRNA and cDNA had been prepared and successful microarray screening had been conducted. From the scanning results, it was found 1 genes were up-regulated and 22 genes were down-regulated by p7 protein of HCV. HCV p7 protein is a trans-regulator. The expression of p7 protein affected the expression spectrum of HCV infected hepatocyte. Results: See Figures 1 and 2, and table 1 . 
